Therapy and prognostic significance of regional lymph node involvement in embryonal rhabdomyosarcoma: a report from the European paediatric Soft tissue sarcoma Study Group.
Fiche publication
Date publication
juin 2022
Journal
European journal of cancer (Oxford, England : 1990)
Auteurs
Membres identifiés du Cancéropôle Est :
Dr BERNIER-CHASTAGNER Valérie
Tous les auteurs :
Ben-Arush M, Minard-Colin V, Scarzello G, Fajardo RD, Terwisscha Van Scheltinga S, Bernier V, Jenney M, Gallego S, Zanetti I, Cesen M, Merks JHM, Bisogno G
Lien Pubmed
Résumé
Regional lymph node disease (N1) is a component of the risk-based treatment stratification in rhabdomyosarcoma (RMS). The purpose of this study was to determine the contribution of nodal disease to the prognosis of patients with non-metastatic embryonal RMS (ERMS) and analyse their outcome by treatment received.
Mots clés
Chemotherapy, Embryonal rhabdomyosarcoma, Lymph node involvement, Pediatric oncology
Référence
Eur J Cancer. 2022 06 25;172:119-129